Tag: Lillys
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
The introduction of the anti-obesity drug Zepbound by Eli Lilly & Co. is projected to have a significant…
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.
The Food and Drug Administration (FDA) recently approved Eli Lilly's obesity drug Zepbound, also known as tirzepatide, as…
Lilly’s Zepbound price cut could help customers — and boost profits
Overall, while Lilly’s move to offer discounted vials of Zepbound may seem like a positive step towards increasing…